These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 25025378)
1. ERCC1 Cys8092Ala and XRCC1 Arg399Gln polymorphisms predict progression-free survival after curative radiotherapy for nasopharyngeal carcinoma. Jin H; Xie X; Wang H; Hu J; Liu F; Liu Z; Zhou J; Zhang Y; Xi X; Hu B; Liao Y; Tang J PLoS One; 2014; 9(7):e101256. PubMed ID: 25025378 [TBL] [Abstract][Full Text] [Related]
2. Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma. Xie X; Jin H; Hu J; Zeng Y; Zhou J; Ouyang S; Yang W; Hu B; Wang H Oncol Rep; 2014 Jan; 31(1):223-31. PubMed ID: 24173110 [TBL] [Abstract][Full Text] [Related]
3. Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in nasopharyngeal carcinoma. Xie X; Wang H; Jin H; Ouyang S; Zhou J; Hu J; Xi X; Luo J; Zhang Y; Hu B Radiat Oncol; 2013 May; 8():117. PubMed ID: 23663243 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapy. Chen C; Wang F; Wang Z; Li C; Luo H; Liang Y; An X; Shao J; Li Y Cancer Chemother Pharmacol; 2013 Aug; 72(2):315-22. PubMed ID: 23712330 [TBL] [Abstract][Full Text] [Related]
5. Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma. Hui EP; Ma BB; Chan KC; Chan CM; Wong CS; To KF; Chan AW; Tung SY; Ng WT; Cheng AC; Lee VH; Chan SL; Loong HH; Kam MK; Leung SF; Ho R; Mo F; Ngan RK; Chan AT Cancer; 2015 Aug; 121(16):2720-9. PubMed ID: 25946469 [TBL] [Abstract][Full Text] [Related]
7. Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma. Yin Z; Zhou B; He Q; Li M; Guan P; Li X; Cui Z; Xue X; Su M; Ma R; Bai W; Xia S; Jiang Y; Xu S; Lv Y; Li X BMC Cancer; 2009 Dec; 9():439. PubMed ID: 20003463 [TBL] [Abstract][Full Text] [Related]
8. Genetic Polymorphisms Along with Dietary and Environmental Factors Enhance the Susceptibility to Nasopharyngeal Carcinoma in Nagaland of Northeast India. Keppen C; Barooah P; Borthakur P; Saikia S; Deka M; Bhattacharjee S; Keppen J; Khamo V; Medhi S Biochem Genet; 2020 Aug; 58(4):533-550. PubMed ID: 32557268 [TBL] [Abstract][Full Text] [Related]
9. Association of DNA base-excision repair XRCC1, OGG1 and APE1 gene polymorphisms with nasopharyngeal carcinoma susceptibility in a Chinese population. Li Q; Wang JM; Peng Y; Zhang SH; Ren T; Luo H; Cheng Y; Wang D Asian Pac J Cancer Prev; 2013; 14(9):5145-51. PubMed ID: 24175791 [TBL] [Abstract][Full Text] [Related]
10. Distribution and haplotype associations of XPD Lys751Gln, XRCC1 Arg280His and XRCC1 Arg399Gln polymorphisms with nasopharyngeal carcinoma in the Malaysian population. Visuvanathan S; Chong PP; Yap YY; Lim CC; Tan MK; Lye MS Asian Pac J Cancer Prev; 2014; 15(6):2747-51. PubMed ID: 24761895 [TBL] [Abstract][Full Text] [Related]
11. DNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinoma. Han JY; Yoon KA; Park JH; Lee YJ; Lee GK; Han JH; Yoon SJ; Yun T; Kim HT; Lee JS Cancer; 2011 Jul; 117(14):3201-8. PubMed ID: 21264830 [TBL] [Abstract][Full Text] [Related]
12. Genetic Polymorphisms in ERCC1 Gene and Their Association with Response to Radiotherapy in Moroccan Patients with Nasopharyngeal Carcinoma. Benzeid R; Gihbid A; Tawfiq N; Benchakroun N; Bendahhou K; Benider A; Guensi A; El Benna N; Filali Maltouf A; Attaleb M; Chaoui I; Khyatti M; El Mzibri M Asian Pac J Cancer Prev; 2023 Jan; 24(1):93-99. PubMed ID: 36708557 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of XRCC1 and XRCC2 DNA Repair genes and Interaction with Environmental Factors Influence the Risk of Nasopharyngeal Carcinoma in Northeast India. Singh SA; Ghosh SK Asian Pac J Cancer Prev; 2016; 17(6):2811-9. PubMed ID: 27356695 [TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population. Cao Y; Miao XP; Huang MY; Deng L; Hu LF; Ernberg I; Zeng YX; Lin DX; Shao JY BMC Cancer; 2006 Jun; 6():167. PubMed ID: 16796765 [TBL] [Abstract][Full Text] [Related]
15. Significance of XRCC1 Codon399 polymorphisms in Chinese patients with locally advanced nasopharyngeal carcinoma treated with radiation therapy. Zhai XM; Hu QC; Gu K; Wang JP; Zhang JN; Wu YW Asia Pac J Clin Oncol; 2016 Mar; 12(1):e125-32. PubMed ID: 23910235 [TBL] [Abstract][Full Text] [Related]
16. Phase II study of satraplatin and prednisone in patients with metastatic castration-resistant prostate cancer: a pharmacogenetic assessment of outcome and toxicity. Figg WD; Chau CH; Madan RA; Gulley JL; Gao R; Sissung TM; Spencer S; Beatson M; Aragon-Ching J; Steinberg SM; Dahut WL Clin Genitourin Cancer; 2013 Sep; 11(3):229-37. PubMed ID: 23684781 [TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum. Liao WY; Shih JY; Chang GC; Cheng YK; Yang JC; Chen YM; Yu CJ J Thorac Oncol; 2012 Jun; 7(6):973-81. PubMed ID: 22551904 [TBL] [Abstract][Full Text] [Related]
18. XRCC1 and ERCC1 polymorphisms are related to susceptibility and survival of colorectal cancer in the Chinese population. Dai Q; Luo H; Li XP; Huang J; Zhou TJ; Yang ZH Mutagenesis; 2015 May; 30(3):441-9. PubMed ID: 25690281 [TBL] [Abstract][Full Text] [Related]
19. XRCC1 codon 399Gln polymorphism is associated with radiotherapy-induced acute dermatitis and mucositis in nasopharyngeal carcinoma patients. Li H; You Y; Lin C; Zheng M; Hong C; Chen J; Li D; Au WW; Chen Z Radiat Oncol; 2013 Feb; 8():31. PubMed ID: 23375119 [TBL] [Abstract][Full Text] [Related]
20. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. Sreeja L; Syamala VS; Syamala V; Hariharan S; Raveendran PB; Vijayalekshmi RV; Madhavan J; Ankathil R J Cancer Res Clin Oncol; 2008 Jun; 134(6):645-52. PubMed ID: 17952468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]